Some options are designed to reach higher maintenance doses to maximise appetite suppression, while others prioritise gradual escalation to improve tolerability
More than half a billion people are living with diabetes worldwide and it is estimated that by 2045 there will be 693 million people diagnosed with the condition [1]
During this window, you'll discover your ideal dose, tolerate side effects, and confirm that semaglutide fits your lifestyle
When you start taking insulin, you may regain some of the weight you lost before your diabetes diagnosis
hiPSC culture for GRN knockdown and microglia differentiation The hiPSC lines used in this study were CRISPRi hiPSC 107 , an iPSC line with a constitutive CRISPRi machinery (dCas9-BFP-KRAB), and iTF-hiPSC 74 , an iPSC line expressing inducible CRISPRi machinery and inducibly expressing six transcription factors that enable the generation of microglia-like cells